Overview

A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
To assess effectiveness of Macugen for treatment of neovascular age-related macular degeneration by measuring the evolution of visual acuity. Treatment duration, frequency of administration and combination with other treatments will also be evaluated.
Details
Lead Sponsor:
Pfizer